KLF5 and prostate carcinoma: Moreover, PI3K/AKT pathway and expression of HIF-1α, VEGF, PDGF-A, and PDGF-B are activated by KLF5 loss and blocked by KLF5 overexpression in PTEN-deficient prostate cancer (Ci et al., 2015).